MM
Mathew S. Maurer
Highly rated in
24
conditions

Dr. Mathew S. Maurer

CUMC/Vivian & Seymour Milstein Family Heart Center
New York, NY
Highly rated in
24
conditions
Specialties:Cardiology
Experience:31 Years
Clinical Trials:Currently Recruiting for 5 Trials
Accepts:New PatientsMedicare
Highly rated in
24
conditions
About|Expertise|Insurance|Location|Research
Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Check Dr. Mathew S. Maurer's experience treating your condition:
About Dr. Mathew S. Maurer

Mathew Maurer is a Cardiologist in New York, New York. Maurer has been practicing medicine for over 31 years and is highly rated in 24 conditions, according to our data. His top areas of expertise are Cardiac Amyloidosis, Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Heart Transplant, and Aortic Valve Replacement. He is licensed to treat patients in New York. Maurer is currently accepting new patients.

His clinical research consists of co-authoring 335 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mathew S. Maurer it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Mathew S. Maurer accepts the following insurance:

  •  Ambetter
Locations
173 Fort Washington Ave, New York, NY 10032
Other Locations
622 W 168th St, New York, NY 10032
Background & Education
Graduate Institution
Icahn School Of Medicine At Mount Sinai, 1992
Specialties
Cardiology
Licenses
Internal Medicine in NY
Hospital Affiliations
NewYork-Presbyterian/Weill Cornell Medical Center
NewYork-Presbyterian/Columbia University Irving Medical Center
Greenwich Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials
A Pilot Study Using Amyloid Reactive Peptide AT-01(124I-evuzamitide) in Transthyretin Cardiac Amyloidosis for Early Detection, Assessment of Cardiac Involvement in Rare Variants and Quantification of Extra-Cardiac Amyloidosis
Enrollment Status: Recruiting
Publish Date: December 02, 2022
Intervention Type: Drug
Study Phase: Phase 2
Identifying Subclinical Transthyretin Cardiac Amyloidosis in Asymptomatic Carriers of the V122I TTR Allele
Enrollment Status: Recruiting
Publish Date: November 22, 2022
Impact of a High Energy and High Protein Nutrition Supplementation Intervention on Outcomes in Patients With Advanced Heart Failure
Enrollment Status: Recruiting
Publish Date: July 20, 2022
Intervention Type: Dietary Supplement, Other
Study Phase: Not Applicable
Screening for Cardiac Amyloidosis With Nuclear Cardiology for Minority Populations
Enrollment Status: Recruiting
Publish Date: May 23, 2022
Intervention Type: Drug
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in Transthyretin Amyloid (ATTR) Cardiomyopathy
Enrollment Status: Recruiting
Publish Date: March 17, 2022
Intervention Type: Drug
Study Drug: Empagliflozin
Study Phase: Phase 4
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 1, Open-label, Dose Escalation Study of Intravenous PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Enrollment Status: Terminated
Publish Date: August 20, 2020
Intervention Type: Drug
Study Phase: Phase 1
Effects of Home-delivered Low-sodium Meals in Older Adults Following Heart Failure Hospitalization.
Enrollment Status: Completed
Publish Date: July 27, 2017
Intervention Type: Other
Study Phase: Not Applicable
Efficacy of Treating Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF) on Ventricular Function, Exercise Capacity and Health Status
Enrollment Status: Completed
Publish Date: March 10, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials -
334 Total Publications
Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling.
Journal: Circulation. Genomic and precision medicine
Published: October 17, 2022
Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
GS
Gregg W. Stone
Dr. Gregg W. Stone
Cardiology | Interventional Cardiology
Highly rated in
31
conditions
Cardiology
Interventional Cardiology

New York Office

161 Fort Washington Ave, 
New York, NY 
 0.1 mi

Gregg Stone is a Cardiologist and an Interventional Cardiologist in New York, New York. Stone has been practicing medicine for over 41 years and is highly rated in 31 conditions, according to our data. His top areas of expertise are Heart Attack, Coronary Heart Disease, Acute Coronary Syndrome, Percutaneous Coronary Intervention (PCI), and Angioplasty. He is licensed to treat patients in New York.

AK
Dr. Annapoorna S. Kini
Cardiology | Interventional Cardiology
Highly rated in
36
conditions
Cardiology
Interventional Cardiology

Mount Sinai Health System

The Lauder Family Cardiovascular Ambulatory Center Of Mount Sinai Heart

1190 5th Ave, 
New York, NY 
 3.5 mi

Annapoorna Kini is a Cardiologist and an Interventional Cardiologist in New York, New York. Kini has been practicing medicine for over 32 years and is highly rated in 36 conditions, according to our data. Her top areas of expertise are Coronary Heart Disease, Atherosclerosis, Heart Attack, Atherectomy, and Percutaneous Coronary Intervention (PCI). She is licensed to treat patients in New York. Kini is currently accepting new patients.

AC
Antonio B. Colombo
Dr. Antonio B. Colombo
Cardiology | Interventional Cardiology
Highly rated in
35
conditions
Cardiology
Interventional Cardiology

161 Fort Washington Ave, 
New York, NY 
 0.1 mi

Antonio Colombo is a Cardiologist and an Interventional Cardiologist in New York, New York. Colombo has been practicing medicine for over 48 years and is highly rated in 35 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Tricuspid Regurgitation, Atherectomy, and Angioplasty. He is licensed to treat patients in Connecticut and New York.